Yuki Yuza

3.6k total citations
74 papers, 1.4k citations indexed

About

Yuki Yuza is a scholar working on Molecular Biology, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Yuki Yuza has authored 74 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Hematology and 15 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Yuki Yuza's work include Acute Lymphoblastic Leukemia research (14 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Yuki Yuza is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Chronic Myeloid Leukemia Treatments (10 papers). Yuki Yuza collaborates with scholars based in Japan, United States and Greece. Yuki Yuza's co-authors include Matthew Meyerson, Kwok‐Kin Wong, Hongbin Ji, Hisashi Yamada, Balázs Halmos, Susumu Kobayashi, Daniel G. Tenen, Masaharu Akiyama, Takaaki Yanagisawa and Mitsuyoshi Urashima and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yuki Yuza

68 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Yuza Japan 16 692 574 524 166 144 74 1.4k
R. Brian Mitchell United States 11 518 0.7× 478 0.8× 363 0.7× 93 0.6× 183 1.3× 17 1.4k
Yoichi Nakamura Japan 21 610 0.9× 936 1.6× 553 1.1× 67 0.4× 59 0.4× 92 1.6k
Thomas Licht Germany 23 757 1.1× 715 1.2× 226 0.4× 94 0.6× 73 0.5× 63 1.8k
Carsten Grüllich Germany 25 557 0.8× 493 0.9× 479 0.9× 258 1.6× 68 0.5× 90 1.5k
Andreas Trojan Switzerland 22 339 0.5× 741 1.3× 295 0.6× 151 0.9× 206 1.4× 64 1.8k
Julio C. Barredo United States 22 889 1.3× 316 0.6× 256 0.5× 442 2.7× 215 1.5× 73 2.0k
Bart C. Kuenen Netherlands 17 511 0.7× 519 0.9× 264 0.5× 159 1.0× 80 0.6× 31 1.2k
Arnauld Verschuur France 23 636 0.9× 234 0.4× 314 0.6× 66 0.4× 151 1.0× 89 1.3k
Pavani Chalasani United States 18 344 0.5× 478 0.8× 225 0.4× 47 0.3× 102 0.7× 82 1.1k
Damien Thomson Australia 22 294 0.4× 571 1.0× 630 1.2× 41 0.2× 127 0.9× 51 1.7k

Countries citing papers authored by Yuki Yuza

Since Specialization
Citations

This map shows the geographic impact of Yuki Yuza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Yuza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Yuza more than expected).

Fields of papers citing papers by Yuki Yuza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Yuza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Yuza. The network helps show where Yuki Yuza may publish in the future.

Co-authorship network of co-authors of Yuki Yuza

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Yuza. A scholar is included among the top collaborators of Yuki Yuza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Yuza. Yuki Yuza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makimoto, Atsushi, Hiroyuki Fujisaki, Kimikazu Matsumoto, et al.. (2024). Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects. Cancers. 16(3). 544–544. 7 indexed citations
2.
3.
Hayashi, Hiroshi, Atsushi Makimoto, & Yuki Yuza. (2024). Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective. Cancers. 16(4). 723–723. 15 indexed citations
4.
Makimoto, Atsushi, Motoaki Chin, Katsuyoshi Koh, et al.. (2024). Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial. International Journal of Clinical Oncology. 29(5). 629–637. 1 indexed citations
5.
6.
Suzuki, Nao, Hiroki Takeuchi, Atsushi Manabe, et al.. (2023). Challenges to Widespread Use of Fertility Preservation Facilities for Pediatric Cancer Patients in Japan. Journal of Adolescent and Young Adult Oncology. 13(1). 197–202.
7.
Shima, Haruko, Akiko Kada, Akihiko Tanizawa, et al.. (2022). Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia. Pediatric Blood & Cancer. 69(8). e29699–e29699. 14 indexed citations
8.
Taku, Kanako, et al.. (2022). Role of Peer Support in Posttraumatic Growth Among Adolescent and Young Adult Cancer Patients and Survivors. Journal of Adolescent and Young Adult Oncology. 12(4). 503–511. 5 indexed citations
9.
Uda, Kazuhiro, et al.. (2022). Natto intake is a risk factor of Bacillus subtilis bacteremia among children undergoing chemotherapy for childhood cancer: A case-control study. Journal of Infection and Chemotherapy. 29(3). 329–332. 1 indexed citations
10.
Yamaji, Noyuri, et al.. (2022). Information needs of children with leukemia and their parents’ perspectives of their information needs: a qualitative study. BMC Pediatrics. 22(1). 414–414. 10 indexed citations
11.
Saito, Yuya, Mitsuyoshi Urashima, Yoshiyuki Takahashi, et al.. (2021). Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan. Bone Marrow Transplantation. 56(9). 2173–2182. 2 indexed citations
12.
Moritake, Hiroshi, Shiro Tanaka, Takako Miyamura, et al.. (2020). The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study. Pediatric Blood & Cancer. 68(1). e28736–e28736. 12 indexed citations
13.
Urayama, Kevin Y., Junji Tanaka, Koji Kato, et al.. (2019). Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults. Biology of Blood and Marrow Transplantation. 25(8). 1597–1602. 14 indexed citations
14.
Saito, Yuya, et al.. (2019). Ewing’s Sarcoma with Extension into Superior Vena Cava and Right Atrium. Indian Journal of Surgical Oncology. 10(1). 98–100.
15.
Hama, Takanori, Shu Kondo, Yuki Yuza, et al.. (2012). Copy Number Amplification of the PIK3CA Gene Is Associated with Poor Prognosis in Non-lymph node metastatic Head and Neck Squamous Cell Carcinoma. BMC Cancer. 12(1). 416–416. 50 indexed citations
16.
Cho, Jeonghee, Sandra Pastorino, Qing Zeng, et al.. (2011). Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies. Cancer Research. 71(24). 7587–7596. 53 indexed citations
17.
Kakee, Naoko, Yasushi Ishida, Keiko Asami, et al.. (2011). Validation of the Japanese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module. Health and Quality of Life Outcomes. 9(1). 22–22. 42 indexed citations
18.
Sos, Martin L., Haridas B. Rode, Stefanie Heynck, et al.. (2010). Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance Mutation. Cancer Research. 70(3). 868–874. 175 indexed citations
19.
Akiyama, Masaharu, et al.. (2007). Antitumor activity of G-quadruplex-interactive agent TMPyP4 in K562 leukemic cells. Molecular Cancer Therapeutics. 6. 1 indexed citations
20.
Taki, Tomohiko, Masaharu Akiyama, Shinobu Saito, et al.. (2005). The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22. Oncogene. 24(33). 5191–5197. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Brian Mitchell Breakdown of academic impact, for papers by Yoichi Nakamura Breakdown of academic impact, for papers by Thomas Licht Breakdown of academic impact, for papers by Carsten Grüllich Breakdown of academic impact, for papers by Andreas Trojan Breakdown of academic impact, for papers by Julio C. Barredo Breakdown of academic impact, for papers by Bart C. Kuenen Breakdown of academic impact, for papers by Arnauld Verschuur Breakdown of academic impact, for papers by Pavani Chalasani Breakdown of academic impact, for papers by Damien Thomson
Rankless by CCL
2026